|
Prescribed drug
|
Frequency in initial 50 volunteers (%)
|
|
Beta Blocker
|
7 (14%)
|
|
Statin
|
29 (58%)
|
|
ACE Inhibitor
|
22 (44%)
|
|
Ca+ channel
blocker
|
10 (20%)
|
|
PPI
|
11 (22%)
|
|
Diuretic
|
12 (24%)
|
|
Inotrope
|
4 (8%)
|
|
Biguinide
|
11 (22%)
|
|
Anteplatelet therapy
|
37 (74%)
|
|
Sulphonylureas
|
5 (10%)
|
|
Insulin
|
4 (8%)
|
|
Comorbidities/Previous interventions
|
|
|
Diabetes
|
5 (10%)
|
|
Current coronary artery
disease
|
7 (14%)
|
|
Hypertension (controlled)
|
22 (44%)
|
|
Previous PTCA (>12
months)
|
1 (2%)
|
|
Previous CABG (>12
months)
|
2 (4%)
|
|
Previous MI
|
1 (2%)
|
|
|
PTCA
– Percutaneous transluminal coronary angioplasty
ABG
– Coronary artery bypass graft